Dow Up 0.51% Nasdaq Up 0.24%

Cleveland BioLabs, Inc. (CBLI)

-NasdaqCM
0.39 Down 0.01(2.26%) Nov 21, 3:37PM EST
Prev Close:0.40
Open:0.40
Bid:N/A
Ask:0.72 x 200
1y Target Est:2.00
Beta:3.49
Next Earnings Date:N/A
Day's Range:0.38 - 0.40
52wk Range:0.33 - 1.40
Volume:94,684
Avg Vol (3m):242,649
Market Cap:22.29M
P/E (ttm):N/A
EPS (ttm):-0.20
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CBLI

Comparison

Symbol% ChgMkt Cap
CBLIDown 2.26%22.29M
AMGNUp 0.08%123.84B
AZNUp 0.47%94.17B
OSIRUp 0.46%450.28M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with significant medical need. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback